Pietrosimone

Pietrosimone sells advanced skincare formulated around bioactive peptides, growth factors and encapsulated delivery systems. The line spans cleansers, serums, creams and targeted treatments priced USD 65-220, placing it in the premium tier. Distribution is DTC through pietrosimone.com and the brand’s New York City skin studio; no wholesale retail. Products are compounded in small European runs, air-shipped refrigerated and time-stamped for freshness. The hero “PS-7 Bio-Serum” combines seven signal peptides with micro-encapsulated copper chlorophyllin and is marketed as a needle-free firming alternative. Clinical data posted on-site claims 32 % wrinkle-depth reduction at eight weeks, underpinning the science-first positioning. Core clientele is 30-55, skincare-literate professionals who already use retinoids or devices and want next-level actives without injectables. They value visible results, ingredient transparency and the concierge chat support that adapts routines every 60 days. Sustainability is secondary; performance is the primary purchase driver. Pietrosimone competes in the physician-dispensed / clinical “pro-grade” space but sidesteps doctor offices by selling direct and publishing third-party lab reports for every batch. Refrigerated logistics, peptide freshness dating and algorithm-driven regimen tweaks create switching costs that mass premium brands cannot match.